Trending...
- Eric Bellinger Debuts "Cry In Front Of You" Live Following Tamla Motown Signing
- On the 296th Anniversary of the Ceremony That Made His Ancestor Emperor, a Cherokee Descendant Publishes the Novel That Restores Him
- The Team of Atlas Elite Entertainment honors Rodney F Crews
SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets announced record revenues for 2022. Revenue growth in 2022 was dramatic, increasing over 60% over 2021 revenue.
"We are pleased with Kurin's success, as demonstrated by the impressive growth over 2021, which also saw a large revenue increase over the prior year," said Bob Rogers, CEO of Kurin, Inc. "Our fourth quarter revenue reflected our highest sales quarter by some distance and we are very well positioned for continued strong growth in 2023."
"In addition, we continue to roll out our proprietary Advance™ push-button needle, providing vertical integration that increases our shareholder value," said Mr. Rogers. "We continue to build upon the company's strong financial position and have accelerated our hiring to accommodate this growth."
Kurin's revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Kurin is a simply better and more sustainable approach over conventional mechanical diversion. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and the life-threatening C. diff. infection.
More on The Californer
About Kurin, Inc.
Kurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com.
Contacts
Matt Heindel
Kurin, Inc.
858-752-9514
mattheindel@kurin.com
"We are pleased with Kurin's success, as demonstrated by the impressive growth over 2021, which also saw a large revenue increase over the prior year," said Bob Rogers, CEO of Kurin, Inc. "Our fourth quarter revenue reflected our highest sales quarter by some distance and we are very well positioned for continued strong growth in 2023."
"In addition, we continue to roll out our proprietary Advance™ push-button needle, providing vertical integration that increases our shareholder value," said Mr. Rogers. "We continue to build upon the company's strong financial position and have accelerated our hiring to accommodate this growth."
Kurin's revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Kurin is a simply better and more sustainable approach over conventional mechanical diversion. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and the life-threatening C. diff. infection.
More on The Californer
- California: Governor Newsom announces clemency actions
- NOW AVAILABLE -Local only or statewide exposure in one publication
- PlanetAI Nature Space (PNS), certificadora Europea, lanza su plataforma EUDR-PNS Ready basada en IA, satélites y trazabilidad blockchain
- Digital Avnue Launches specialized Video Services for California Business Owners
- 40th Annual California Strawberry Festival Features Designs And Crafts From Nearly 150 Artisans
About Kurin, Inc.
Kurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com.
Contacts
Matt Heindel
Kurin, Inc.
858-752-9514
mattheindel@kurin.com
Filed Under: Business
0 Comments
Latest on The Californer
- Summit Acquisitions Group Inc. Expands Cash Home Buying Services in Sacramento & East Bay
- On Good Friday, Civil Rights Attorney Pamela Price Calls Out San Leandro Police and Appointed DA for "Evil Treatment" of Homeless Man
- DriveYo Signs Cybersecurity Prodigy and Open-Source Pioneer Utkarsh Lubal
- Professor Gary Surdam to Speak at Japan's Largest AI & Web3 Conference, TEAMZ Summit 2026
- UK Financial Ltd Confirms CATEX Exchange Integration of SMPRA and LTNS 1 Ahead of Compliance-Based Trading Activation
- Thursday's Hair Solutions Launches New Active Lifestyle Program for 24/7 Hair System Wearers
- Iran war is delaying launch of Crypto Corner Shop!
- Governor Newsom turns on largest public broadband network, California connects first rural community to internet
- ABLD.app Launches AREL: The First Wearable Legal Notice for ADA Accommodations
- Ashikaga Flower Park's "Great Wisteria Festival 2026"
- California Web Coders Expands Expertise in MERN Full Stack Development Across California
- Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
- Snell & Wilmer Welcomes Counsel Herman Enayati to the Orange County Office
- Deborah E. Jones Introduces Emotional Sovereignty, a Powerful New Book on Emotional Mastery, Resilience, and Intentional Living
- Governor Newsom welcomes approval of Diablo Canyon license renewals, delivering on California's commitment to a clean and reliable grid
- Justplug Solves High Cost and Outage Challenges of Rural Grid-Tied Solar With Off-Grid Conversion
- "memoirs Of The End," A New Novel Depicting Life After The Ai Singularity
- New Research Identifies "The Busy Effect": 89% of Americans Want a Laid-Back Vacation — Only 15% Actually Achieve It
- Alchemy 43 Appoints Shane Smith as CEO to Drive Operational Performance and Scalable Growth
- Best Spiritual Healing, Meditation & Retreats in Sedona — Rise Meditation Helps You Find and Book Transformational Experiences